These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 33796258)
21. Using informative features in machine learning based method for COVID-19 drug repurposing. Aghdam R; Habibi M; Taheri G J Cheminform; 2021 Sep; 13(1):70. PubMed ID: 34544500 [TBL] [Abstract][Full Text] [Related]
22. Repurposing Drugs for COVID-19: An Approach for Treatment in the Pandemic. Khadka S; Yuchi A; Shrestha DB; Budhathoki P; Al-Subari SMM; Ziad Alhouzani TM; Anwar Butt I Altern Ther Health Med; 2020 Aug; 26(S2):100-107. PubMed ID: 32827400 [TBL] [Abstract][Full Text] [Related]
23. Artificial intelligence, machine learning, and drug repurposing in cancer. Tanoli Z; Vähä-Koskela M; Aittokallio T Expert Opin Drug Discov; 2021 Sep; 16(9):977-989. PubMed ID: 33543671 [No Abstract] [Full Text] [Related]
24. Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment. Taibe NS; Kord MA; Badawy MA; Shytaj IL; Elhefnawi MM Ther Adv Respir Dis; 2022; 16():17534666221132736. PubMed ID: 36282077 [TBL] [Abstract][Full Text] [Related]
25. Deep Learning in the Quest for Compound Nomination for Fighting COVID-19. Mernea M; Martin EC; Petrescu AJ; Avram S Curr Med Chem; 2021; 28(28):5699-5732. PubMed ID: 33441063 [TBL] [Abstract][Full Text] [Related]
26. Recent advances in drug repurposing using machine learning. Urbina F; Puhl AC; Ekins S Curr Opin Chem Biol; 2021 Dec; 65():74-84. PubMed ID: 34274565 [TBL] [Abstract][Full Text] [Related]
27. Proteomics and Machine Learning Approaches Reveal a Set of Prognostic Markers for COVID-19 Severity With Drug Repurposing Potential. Suvarna K; Biswas D; Pai MGJ; Acharjee A; Bankar R; Palanivel V; Salkar A; Verma A; Mukherjee A; Choudhury M; Ghantasala S; Ghosh S; Singh A; Banerjee A; Badaya A; Bihani S; Loya G; Mantri K; Burli A; Roy J; Srivastava A; Agrawal S; Shrivastav O; Shastri J; Srivastava S Front Physiol; 2021; 12():652799. PubMed ID: 33995121 [TBL] [Abstract][Full Text] [Related]
28. Repurposing potential of FDA-approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm. Verma AK; Aggarwal R Chem Biol Drug Des; 2021 Apr; 97(4):836-853. PubMed ID: 33289334 [TBL] [Abstract][Full Text] [Related]
29. Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks. Nam Y; Lucas A; Yun JS; Lee SM; Park JW; Chen Z; Lee B; Ning X; Shen L; Verma A; Kim D J Transl Med; 2023 Jun; 21(1):415. PubMed ID: 37365631 [TBL] [Abstract][Full Text] [Related]
30. How do you feel during the COVID-19 pandemic? A survey using psychological and linguistic self-report measures, and machine learning to investigate mental health, subjective experience, personality, and behaviour during the COVID-19 pandemic among university students. Herbert C; El Bolock A; Abdennadher S BMC Psychol; 2021 Jun; 9(1):90. PubMed ID: 34078469 [TBL] [Abstract][Full Text] [Related]
31. Applications of artificial intelligence in COVID-19 pandemic: A comprehensive review. Khan M; Mehran MT; Haq ZU; Ullah Z; Naqvi SR; Ihsan M; Abbass H Expert Syst Appl; 2021 Dec; 185():115695. PubMed ID: 34400854 [TBL] [Abstract][Full Text] [Related]
32. Delivering Benefits at Speed Through Real-World Repurposing of Off-Patent Drugs: The COVID-19 Pandemic as a Case in Point. Rogosnitzky M; Berkowitz E; Jadad AR JMIR Public Health Surveill; 2020 May; 6(2):e19199. PubMed ID: 32374264 [TBL] [Abstract][Full Text] [Related]
33. Drug Repurposing Approaches to Combating Viral Infections. Trivedi J; Mohan M; Byrareddy SN J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33238464 [TBL] [Abstract][Full Text] [Related]
34. Identification of potential pan-coronavirus therapies using a computational drug repurposing platform. Hwang W; Han N Methods; 2022 Jul; 203():214-225. PubMed ID: 34767922 [TBL] [Abstract][Full Text] [Related]
35. Repurposing anticancer drugs for the management of COVID-19. El Bairi K; Trapani D; Petrillo A; Le Page C; Zbakh H; Daniele B; Belbaraka R; Curigliano G; Afqir S Eur J Cancer; 2020 Dec; 141():40-61. PubMed ID: 33125946 [TBL] [Abstract][Full Text] [Related]
36. Repositioning of Drugs to Counter COVID-19 Pandemic - An Insight. Akilesh SM; J R; Palanisamy D; Wadhwani A Curr Pharm Biotechnol; 2021; 22(2):192-199. PubMed ID: 32867651 [TBL] [Abstract][Full Text] [Related]
37. Molecular-evaluated and explainable drug repurposing for COVID-19 using ensemble knowledge graph embedding. Islam MK; Amaya-Ramirez D; Maigret B; Devignes MD; Aridhi S; Smaïl-Tabbone M Sci Rep; 2023 Mar; 13(1):3643. PubMed ID: 36871056 [TBL] [Abstract][Full Text] [Related]
38. Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial 'in hibernation', ready for rapid activation. Lim WS; Brittain C; Duley L; Edwards S; Gordon S; Montgomery A; Nguyen-Van-Tam J; Read R; Whitham D; Whynes D; Woodhead M; Wootton D Health Technol Assess; 2015 Feb; 19(16):1-78, vii-viii. PubMed ID: 25716702 [TBL] [Abstract][Full Text] [Related]
39. Prediction of Online Psychological Help-Seeking Behavior During the COVID-19 Pandemic: An Interpretable Machine Learning Method. Liu H; Zhang L; Wang W; Huang Y; Li S; Ren Z; Zhou Z Front Public Health; 2022; 10():814366. PubMed ID: 35309216 [TBL] [Abstract][Full Text] [Related]